342 related articles for article (PubMed ID: 18178194)
21. Luteal-phase ovarian stimulation is feasible for producing competent oocytes in women undergoing in vitro fertilization/intracytoplasmic sperm injection treatment, with optimal pregnancy outcomes in frozen-thawed embryo transfer cycles.
Kuang Y; Hong Q; Chen Q; Lyu Q; Ai A; Fu Y; Shoham Z
Fertil Steril; 2014 Jan; 101(1):105-11. PubMed ID: 24161646
[TBL] [Abstract][Full Text] [Related]
22. Is there a place for corifollitropin alfa in IVF/ICSI cycles? A systematic review and meta-analysis.
Mahmoud Youssef MA; van Wely M; Aboulfoutouh I; El-Khyat W; van der Veen F; Al-Inany H
Fertil Steril; 2012 Apr; 97(4):876-85. PubMed ID: 22277766
[TBL] [Abstract][Full Text] [Related]
23. Effect of the initiation of progesterone supplementation in in vitro fertilization-embryo transfer outcomes: a prospective randomized controlled trial.
Gao J; Gu F; Miao BY; Chen MH; Zhou CQ; Xu YW
Fertil Steril; 2018 Jan; 109(1):97-103. PubMed ID: 29175065
[TBL] [Abstract][Full Text] [Related]
24. Effect of Gonadotrophin-Releasing Hormone Agonist Addition for Luteal Support on Pregnancy Outcome in vitro Fertilization/Intracytoplasmic Sperm Injection Cycles: A Meta-Analysis Based on Randomized Controlled Trials.
Ma X; Du W; Hu J; Yang Y; Zhang X
Gynecol Obstet Invest; 2020; 85(1):13-25. PubMed ID: 31422404
[TBL] [Abstract][Full Text] [Related]
25. Effects of estradiol supplementation during the luteal phase of in vitro fertilization cycles: a meta-analysis.
Jee BC; Suh CS; Kim SH; Kim YB; Moon SY
Fertil Steril; 2010 Feb; 93(2):428-36. PubMed ID: 19342034
[TBL] [Abstract][Full Text] [Related]
26. [Effect of domestic highly purified urinary follicle stimulating hormone on outcomes of in vitro fertilization-embryo transfer in controlled ovarian stimulation].
Ye H; Huang GN; Cao YX; Zhong Y; Huang YH; Zhu GJ; Zhou LM; Chen ZJ; Shi JZ; Zeng Y; Weng N; Huang XF; Yang J; Zhu YM; Li YP; Yi D; Zhuang GL
Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):838-42. PubMed ID: 24444561
[TBL] [Abstract][Full Text] [Related]
27. Elevated early follicular progesterone levels and in vitro fertilization outcomes: a prospective intervention study and meta-analysis.
Hamdine O; Macklon NS; Eijkemans MJ; Laven JS; Cohlen BJ; Verhoeff A; van Dop PA; Bernardus RE; Lambalk CB; Oosterhuis GJ; Holleboom CA; van den Dool-Maasland GC; Verburg HJ; van der Heijden PF; Blankhart A; Fauser BC; Broekmans FJ;
Fertil Steril; 2014 Aug; 102(2):448-454.e1. PubMed ID: 24929258
[TBL] [Abstract][Full Text] [Related]
28. A prospective randomized comparison of routine buserelin acetate and a decreasing dosage of nafarelin acetate with a low-dose gonadotropin-releasing hormone agonist protocol for in vitro fertilization and intracytoplasmic sperm injection.
Takeuchi S; Minoura H; Shibahara T; Tsuiki Y; Noritaka F; Toyoda N
Fertil Steril; 2001 Sep; 76(3):532-7. PubMed ID: 11532477
[TBL] [Abstract][Full Text] [Related]
29. Fresh versus elective frozen embryo transfer in IVF/ICSI cycles: a systematic review and meta-analysis of reproductive outcomes.
Roque M; Haahr T; Geber S; Esteves SC; Humaidan P
Hum Reprod Update; 2019 Jan; 25(1):2-14. PubMed ID: 30388233
[TBL] [Abstract][Full Text] [Related]
30. Which luteal phase support is better for each IVF stimulation protocol to achieve the highest pregnancy rate? A superiority randomized clinical trial.
Gizzo S; Andrisani A; Esposito F; Noventa M; Di Gangi S; Angioni S; Litta P; Gangemi M; Nardelli GB
Gynecol Endocrinol; 2014; 30(12):902-8. PubMed ID: 25268567
[TBL] [Abstract][Full Text] [Related]
31. Oral oestradiol supplementation as luteal support in IVF/ICSI cycles: a prospective, randomized controlled study.
Lin H; Li Y; Li L; Wang W; Zhang Q; Chen X; Yang D
Eur J Obstet Gynecol Reprod Biol; 2013 Apr; 167(2):171-5. PubMed ID: 23287635
[TBL] [Abstract][Full Text] [Related]
32. Luteal phase support in in vitro fertilization.
Yanushpolsky EH
Semin Reprod Med; 2015 Mar; 33(2):118-27. PubMed ID: 25734349
[TBL] [Abstract][Full Text] [Related]
33. Administration of single-dose GnRH agonist in the luteal phase in ICSI cycles: a meta-analysis.
Oliveira JB; Baruffi R; Petersen CG; Mauri AL; Cavagna M; Franco JG
Reprod Biol Endocrinol; 2010 Sep; 8():107. PubMed ID: 20825643
[TBL] [Abstract][Full Text] [Related]
34. Dual trigger with combination of gonadotropin-releasing hormone agonist and human chorionic gonadotropin significantly improves the live-birth rate for normal responders in GnRH-antagonist cycles.
Lin MH; Wu FS; Lee RK; Li SH; Lin SY; Hwu YM
Fertil Steril; 2013 Nov; 100(5):1296-302. PubMed ID: 23993928
[TBL] [Abstract][Full Text] [Related]
35. The role of estrogen support during the luteal phase of in vitro fertilization-embryo transplant cycles: a comparative study between progesterone alone and estrogen and progesterone support.
Lewin A; Benshushan A; Mezker E; Yanai N; Schenker JG; Goshen R
Fertil Steril; 1994 Jul; 62(1):121-5. PubMed ID: 8005275
[TBL] [Abstract][Full Text] [Related]
36. The effect of luteal phase support protocol on cycle outcome and luteal phase hormone profile in long agonist protocol intracytoplasmic sperm injection cycles: a randomized clinical trial.
Ghanem ME; Sadek EE; Elboghdady LA; Helal AS; Gamal A; Eldiasty A; Bakre NI; Houssen M
Fertil Steril; 2009 Aug; 92(2):486-93. PubMed ID: 19464001
[TBL] [Abstract][Full Text] [Related]
37. Gonadotropin-releasing hormone analogue as sole luteal support in antagonist-based assisted reproductive technology cycles.
Bar Hava I; Blueshtein M; Ganer Herman H; Omer Y; Ben David G
Fertil Steril; 2017 Jan; 107(1):130-135.e1. PubMed ID: 28228316
[TBL] [Abstract][Full Text] [Related]
38. Consistent high clinical pregnancy rates and low ovarian hyperstimulation syndrome rates in high-risk patients after GnRH agonist triggering and modified luteal support: a retrospective multicentre study.
Iliodromiti S; Blockeel C; Tremellen KP; Fleming R; Tournaye H; Humaidan P; Nelson SM
Hum Reprod; 2013 Sep; 28(9):2529-36. PubMed ID: 23873146
[TBL] [Abstract][Full Text] [Related]
39. Can Ratios Between Prognostic Factors Predict the Clinical Pregnancy Rate in an IVF/ICSI Program with a GnRH Agonist-FSH/hMG Protocol? An Assessment of 2421 Embryo Transfers, and a Review of the Literature.
Merviel P; Menard M; Cabry R; Scheffler F; Lourdel E; Le Martelot MT; Roche S; Chabaud JJ; Copin H; Drapier H; Benkhalifa M; Beauvillard D
Reprod Sci; 2021 Feb; 28(2):495-509. PubMed ID: 32886340
[TBL] [Abstract][Full Text] [Related]
40. GnRH agonist plus vaginal progesterone for luteal phase support in ICSI cycles: a randomized study.
Aboulghar MA; Marie H; Amin YM; Aboulghar MM; Nasr A; Serour GI; Mansour RT
Reprod Biomed Online; 2015 Jan; 30(1):52-6. PubMed ID: 25456166
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
